Navigation Links
Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin

rom this study have enabled us to make the decision to progress to phase III development of pertuzumab in breast cancer," commented Jean-Jacques Garaud, Head of Development, Roche. "We will be investigating the effectiveness of pertuzumab in the metastatic setting and also exploring its use in early breast cancer prior to surgical removal of the tumour."

About the study This is a non-randomised Phase II study, conducted in two-stages: patients were assessed to ensure that the therapy is tolerable and that there is a reasonable minimum level of activity. Eligible patients must have measurable, centrally-tested progressive HER2 positive breast cancer and had received up to 3 courses of prior chemotherapy plus Herceptin and the disease must have progressed during Herceptin therapy . During the study patients received Herceptin i.v weekly or every 3 weeks at 2 mg/kg or 6 mg/kg respectively and 420mg of pertuzumab i.v. every 3 weeks after a loading dose of 840mg. The criteria to proceed to the 2nd stage were: > 2 partial responses (PR), or 1 PR and 12 patients with stable disease (SD), or 13 patients with SD.

Out of 33 patients who had passed the first assessment point at the time of the data cut off, 1 had a complete response and 5 had partial responses giving a response rate of 18.2%. A further 7 patients have had stabilization of disease lasting 6 months or more (21.2%). Recruitment into stage 2 of the trial is ongoing.

As well as evaluating pertuzumab in breast cancer Roche and Genentech are evaluating pertuzumab in ovarian cancer in combination with other therapies. Results from a phase II platinum resistant ovarian cancer study will be presented at ASCO on Sunday 3rd June 1-4pm.

About breast cancer Breast cancer is the most common cancer among women worldwide (2). Each year more than one million new cases of breast cancer are diagnosed worldwide, and nearly 400,000 people will die of the disease annually. In HER2-positive breast cancer,
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
Post Your Comments:
(Date:8/21/2014)... Mass. , Aug. 21, 2014  Decision ... COPD,  physicians in Brazil ... follow clinical guidelines and commonly prescribe long-acting beta-agonist ... although they do so within current severe cost/coverage ... (FDCs) that are expected to launch in these ...
(Date:8/21/2014)... , N.Y. and HAMBURG, Germany , ... announced it is collaborating with Deutsches Elektronen-Synchrotron ( DESY ... Germany , to speed up management and storage ... Big Data and Analytics architecture based on IBM ... per second of data at peak performance and help ...
(Date:8/21/2014)... Aug. 21, 2014  Seventy-one percent of Americans believe the ... a serious public health and safety issue in ... survey released today by Repass & Partners, a ... "Americans understand the severity of the prescription medication abuse problem ... this very serious health situation facing our country," Rex ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... 2011 Columbia Laboratories, Inc. (Nasdaq: CBRX ) ... announced that the U.S. Food and Drug Administration (FDA) has ... ® (progesterone gel) for the reduction of risk of ... the mid-trimester of pregnancy. The acceptance of the NDA for ...
... (NASDAQ: OMER ) today reported that it has ... P2Y8 and OPN4. P2Y8 (also known as P2RY8) is associated ... white blood cells. ALL is the most common type of ... regulation of circadian rhythms, and could provide a target for ...
Cached Medicine Technology:Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 2Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 3Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 4Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders 2Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders 3Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders 4
(Date:8/21/2014)... CA (PRWEB) August 21, 2014 The costs for ... past two decades, according to new insurance industry studies. The Quotes ... insurance finder to locate affordable plans from all 50 states at ... pays more than $50 for a routine visit or complex surgery ... coverage. Every user of the system will be asked to provide ...
(Date:8/21/2014)... Heights, MI (PRWEB) August 21, 2014 ... emails informing a taxpayer that their federal tax payment ... email domain appears to come from the IRS, “tax@irs.gov”, ... victims to provide personal and financial information. , While ... years now, an uptick in phishing activity is occurring ...
(Date:8/21/2014)... exercise is a challenge. Thankfully, there are Zombies chasing you. ... more than 31,000 health and fitness apps on the market ... use games to increase physical activity. , Gamification is currently ... cash in to help people get fit. Whether or not ... , "It,s just been assumed that gamified apps will work, ...
(Date:8/21/2014)... Texas MD Anderson Cancer Center today announced a new ... screening at a network of community breast care centers ... November, MD Anderson will become the exclusive provider of ... 10 breast care centers, located in Memorial City, The ... the network will expand to Memorial Hermann,s locations in ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Black mothers are ... and here,s one possible reason why: Hospitals in neighborhoods ... than those in areas with more white residents, a ... breast-feeding are much less common in medical centers where ... the U.S. Centers for Disease Control and Prevention reported ...
Breaking Medicine News(10 mins):Health News:Pet Insurance Finder for 50 States Launched at Insurance Website Online 2Health News:Beware Of Phony “Tax Payment Rejected” IRS Emails 2Health News:Playing hunger games: Are gamified health apps putting odds in your favor? 2Health News:MD Anderson and Memorial Hermann to operate breast screening network across Houston area 2Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2
... the nation,s leader in pain prescription monitoring, announced ... with Aetna to offer Aetna,s network of providers ... monitoring process. Ameritox,s patented Rx Guardian(SM) methodology is ... a patented methodology to help physicians assess whether ...
... The Ohio State University , Cardinal Health and ... a collaboration that will invest more than $10 million ... industry, combining Ohio State,s Wright Center of Innovation in ... commercialization expertise for molecular imaging agents.Molecular imaging is one ...
... LINE OF NATURAL, NON-TOXIC AND EFFECTIVE HOUSEHOLD CLEANERS OFFER ... FAMILIES CLEAN AND SAFENEW YORK, April 29 ... Kevin Schwartz and Keith Garber of KAS Direct, founders ... cleaning solutions for households with infants and growing families ...
... Security Intelligence, and Risk Management Tools Now All in One ... ... swine flu, political instability, kidnapping and piracy dominating global headlines, MEDEX ... intelligence across medical, security, travel and risk management disciplines. By ...
... released today by the Center to Expose and Close Animal ... Close Animal Factories (CECAF) will hold a media teleconference to ... "factories." Among the topics will be Smithfield Foods at ... Officials in Mexico are looking at "manure lagoons" and ...
... Action to Protect Public,s Oral HealthCHICAGO, April 29 ... exclusively for the general dentist, reminds legislators that dentistry is ... must be taken into consideration in any effort by Congress ... critical issue for general dentistry is access to care. The ...
Cached Medicine News:Health News:Ameritox(R) Contracts With Aetna for Prescription Drug Monitoring Services 2Health News:The Ohio State University, Cardinal Health, State of Ohio to Invest $10 Million to Advance Medical Imaging Industry 2Health News:Preventative Safety Tips Timed to Swine Flu Outbreak 2Health News:MEDEX Announces New, Enhanced and Customizable Member Center 2Health News:MEDEX Announces New, Enhanced and Customizable Member Center 3Health News:MEDEX Announces New, Enhanced and Customizable Member Center 4Health News:Academy of General Dentistry Access to Care White Paper 2
... Knee System is a long term, quality ... Available in both posterior stabilized and anatomically ... System provides the flexibility needed to address ... ease of identification keeps the user in ...
... Virtual Fluoroscopy software from ... has incorporated ease of ... features such as multiplanar ... models of image guided ...
... T.L.I.F. SG Instruments are the next evolution ... comprehensive and functionally sound instruments.. The T.L.I.F. ... disc removal and disc preparation instruments designed ... Excellent design, a wide range of instrument ...
... is a family of multislice CT scanners. ... Mx8000 also is available in an affordable ... same friendly user interface, advanced applications and ... Dual and Quad systems can be upgraded ...
Medicine Products: